P{GS} insertion at position +2668 (relative to the transcription start site), in an intron.
Expression of sraGS3080 under the control of Scer\GAL4elav-C155 or Scer\GAL4sca-537.4 results in increased ovulation in virgin females compared to control virgin females (the effect is stronger with Scer\GAL4elav-C155). Within 30 minutes in a mating assay, only 20% of virgin females expressing sraGS3080 under the control of Scer\GAL4elav-C155 have mated, compared to 82% of wild-type virgin females. Virgin females expressing sraGS3080 under the control of Scer\GAL4elav-C155 elicit intermediate courtship index (CI) levels (CI is the period of time within the observation period that a male displays any element of courtship behaviour), that are between the level elicited by virgin wild-type females and mated wild-type females. Virgin females expressing sraGS3080 under the control of Scer\GAL4elav-C155 have a high extrusion index (EI, the percentage of a time a female shows extrusion behaviour when being courted by a male) which is nearly comparable to that of wild-type mated females. Homozygous females lay fewer eggs than wild type and most of the eggs are arrested at metaphase I of meiosis. Spontaneous ovulation occurs in 3% of mutant virgin females (virtually no ovulation occurs in wild-type virgin females). The level of ovulation of mutant mated females is not as high as that of wild-type mated females. The mutant females show reduced receptivity after mating (as occurs in wild-type females), but their remating rate 24 hours after mating is significantly higher than that of wild-type females. Receptivity of mutant females is restored earlier than for wild-type females; the remating rate is significantly higher for mutant females compared to wild-type females 10 days after mating.
Mutant animals have a mean longevity of about 32.6 days at 30oC.
sraGS3080/sraKO has abnormal sleep phenotype, suppressible | partially by CanA-14FKO
sraGS3080/sraKO has abnormal sleep phenotype, suppressible | partially by Pp2B-14DKO
sraGS3080/sraKO is an enhancer of abnormal sleep phenotype of CanA-14FKO
sraGS3080/sraKO is an enhancer of abnormal sleep phenotype of Pp2B-14DKO
A CanA-14FKO background partially suppresses the reduction in total sleep found in sraGS3080/sraKO mutants.
A Pp2B-14DKO background partially suppresses the reduction in total sleep found in sraGS3080/sraKO mutants.
Excision of the P{GS} element can restore female fertility.